Bakris, George L.

Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes.

Greene, S. J., Vaduganathan, M., Khan, M. S., Bakris, G. L., Weir, M. R., Seltzer, J. H., Sattar, N., McGuire, D. K., Januzzi, J. L., Stockbridge, N., et al. (2018) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 56

Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations

de Boer, I. H., Bakris, G., & Cannon, C. P. (2018) · JAMA

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 54

Renal denervation for the treatment of resistant hypertension: review and clinical perspective

Iliescu, R., Lohmeier, T. E., Tudorancea, I., Laffin, L., & Bakris, G. L. (2015) · American Journal of Physiology-Renal Physiology

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 50

Type 2 diabetes: RENAAL and IDNT–the emergence of new treatment options

Sica, D. A., & Bakris, G. L. (2002) · The Journal of Clinical Hypertension

Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

Cited by 49

A comparative evaluation of various methods for microalbuminuria screening

Sarafidis, P. A., Riehle, J., Bogojevic, Z., Basta, E., Chugh, A., & Bakris, G. L. (2008) · American Journal of Nephrology

Chronic Kidney Disease and DiabetesClinical Laboratory Practices and Quality Control

Cited by 41

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol

Parati, G., Agabiti-Rosei, E., Bakris, G. L., Bilo, G., Branzi, G., Cecchi, F., Chrostowska, M., De la Sierra, A., Domenech, M., Dorobantu, M., et al. (2018) · BMJ Open

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 39

Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease

Lerma, E., White, W. B., & Bakris, G. (2023) · Postgraduate Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 39

Major advancements in slowing diabetic kidney disease progression: focus on SGLT2 inhibitors

Bakris, G. L. (2019) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 37

Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

Weir, M. R., & Bakris, G. L. (2010) · American Journal of Nephrology

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 26

Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial

White, W. B., Jalil, F., Cushman, W. C., Bakris, G. L., Bergenstal, R., Heller, S. R., Liu, Y., Mehta, C., Zannad, F., & Cannon, C. P. (2018) · Journal of the American Heart Association

Blood Pressure and Hypertension StudiesDiabetes Treatment and Management

Cited by 22

Influence of microalbuminuria in achieving blood pressure goals

Duka, I., & Bakris, G. (2008) · Current Opinion in Nephrology and Hypertension

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 18

Evaluation and Treatment of Patients With Systemic Hypertension

Garg, J., Messerli, A. W., & Bakris, G. L. (2002) · Circulation

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 17

ImmunoDip®: An Improved Screening Method for Microalbuminuria

Davidson, M. B., Bazargan, M., Bakris, G., Peters Harmel, A., Campese, V., & Basta, E. (2004) · American Journal of Nephrology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 9